Coumestrol — Hermetica Encyclopedia
Named Bioactive Compounds · Compound

Coumestrol

Moderate Evidencecompound5 PubMed Studies

Hermetica Superfood Encyclopedia

The Short Answer

Coumestrol is a naturally occurring coumestan phytoestrogen found in legumes such as alfalfa, clover, and soybeans. It exerts its primary effects by competitively binding to estrogen receptors ERα and ERβ, with binding affinities of 94% and 185% relative to estradiol, respectively, making it one of the most potent known dietary phytoestrogens.

5
PubMed Studies
0
Validated Benefits
Synergy Pairings
At a Glance
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordcoumestrol benefits
Synergy Pairings3
Coumestrol close-up macro showing natural texture and detail — rich in estrogenic, antioxidant, anti-inflammatory
Coumestrol — botanical close-up

Health Benefits

Origin & History

Coumestrol growing in natural environment — natural habitat
Natural habitat

Coumestrol is a naturally occurring phytoestrogen belonging to the coumestan class of flavonoids, with highest concentrations found in red clover (1.3 g/100g), alfalfa sprouts (1.60 mg/100g), and raw clover sprouts (14.08 mg/100g). It is extracted from legumes and plant sprouts using solvent-based methods, with its low molecular weight (268.22 Da) enabling ready absorption across cell membranes.

Systematic investigation of coumestrol's estrogenic properties began in 1957 when E. M. Bickoff first identified its activity in ladino clover and alfalfa. Clover and alfalfa have been used in traditional herbalism for hormonal balance and menopausal symptom management, though not specifically for coumestrol isolation. The research notes that comprehensive traditional medicine documentation specific to coumestrol would require additional historical sources.Traditional Medicine

Scientific Research

The research dossier explicitly states that comprehensive human randomized controlled trials are not detailed in the provided sources and no PubMed PMIDs are included. The available evidence consists primarily of in vitro receptor binding studies showing coumestrol binds ERα with IC₅₀ = 11 nM, and animal toxicity studies used to calculate maximum tolerable daily intake of 22 µg/kg body weight.

Preparation & Dosage

Coumestrol prepared as liquid extract — pairs with Other phytoestrogens (isoflavones, lignans), vitamin D3
Traditional preparation

Maximum tolerable daily intake calculated from animal studies is 22 µg/kg body weight (approximately 1.54 mg/day for a 70 kg adult). Dietary sources provide variable amounts: clover sprouts (14.08 mg/100g), kala chana (6.13 mg/100g), alfalfa sprouts (1.60 mg/100g). No standardized extract protocols or therapeutic dosing established in human studies. Consult a healthcare provider before starting any new supplement.

Nutritional Profile

Coumestrol is a pure phytoestrogenic coumestan compound (molecular formula C15H8O5, molecular weight 268.22 g/mol), not a whole food ingredient, therefore it has no macronutrient, vitamin, mineral, or fiber content in isolation. Bioactive composition is 100% coumestrol as the sole active entity when in isolated form. In natural food sources, coumestrol occurs at measurable concentrations: sprouted alfalfa seeds (up to 0.14–1.0 mg/g dry weight), split peas (0.2–2.0 µg/g fresh weight), pinto beans (~0.2 µg/g), spinach (~0.17 µg/g), and Brussels sprouts (trace amounts ~0.02 µg/g). As a polyphenolic coumestan, it contains no caloric value in physiologically relevant doses. Bioavailability notes: oral bioavailability is moderate; coumestrol undergoes intestinal absorption with peak plasma concentrations reached within 1–3 hours post-ingestion. It is subject to phase II hepatic metabolism (glucuronidation and sulfation), enterohepatic recirculation has been documented, and gut microbiota composition significantly influences bioavailability. Protein-bound fraction in plasma is high (>95%, primarily albumin-bound). No dietary reference intake or established tolerable upper limit has been defined by regulatory bodies. Estrogenic potency is estimated at approximately 0.1–0.2% that of 17β-estradiol in vivo, despite high in vitro receptor binding affinity.

How It Works

Mechanism of Action

Coumestrol binds competitively to estrogen receptors ERα and ERβ, with relative binding affinities of approximately 94% and 185% compared to 17β-estradiol, allowing it to function as both an estrogen agonist and partial antagonist depending on tissue context and endogenous estrogen levels. Once bound, the coumestrol-receptor complex translocates to the nucleus and modulates estrogen response element (ERE)-driven gene transcription, influencing genes involved in cell proliferation, bone metabolism, and lipid regulation. Coumestrol also inhibits aromatase (CYP19A1) activity in vitro, potentially modulating local estrogen biosynthesis in hormone-sensitive tissues.

Clinical Evidence

The majority of evidence supporting coumestrol's biological activity comes from in vitro cell studies and animal models, with very limited dedicated human clinical trials. Rodent studies have demonstrated effects on uterine tissue, bone density preservation, and reproductive hormone profiles at doses not directly translatable to human supplementation. Epidemiological observations of populations consuming high-legume diets suggest associations with altered menopausal symptom profiles, but coumestrol is rarely isolated as the sole variable. No large-scale, placebo-controlled human RCTs have established efficacious or safe supplemental doses of isolated coumestrol, making evidence strength low to preliminary overall.

Safety & Interactions

Due to its potent estrogenic activity, coumestrol is contraindicated or should be used with extreme caution in individuals with estrogen receptor-positive (ER+) breast cancer, uterine cancer, or endometriosis, as it may stimulate hormone-sensitive tissue proliferation. Coumestrol may interact with tamoxifen, aromatase inhibitors, and oral contraceptives by competing at estrogen receptors or altering estrogenic signaling, potentially reducing or unpredictably modifying drug efficacy. Pregnant and breastfeeding women should avoid supplemental coumestrol, as phytoestrogens have demonstrated developmental and reproductive effects in animal models at elevated doses. No established safe supplemental dose range exists for isolated coumestrol in humans, and dietary intake from food sources is generally considered far lower risk than concentrated supplemental forms.

Synergy Stack

Hermetica Formulation Heuristic

Frequently Asked Questions

How does coumestrol compare to estradiol in binding strength?
Coumestrol binds estrogen receptor ERβ with approximately 185% the affinity of 17β-estradiol and ERα with about 94% relative affinity, making it exceptionally potent among dietary phytoestrogens. By comparison, the isoflavone genistein binds ERβ at roughly 87% relative affinity, highlighting coumestrol's superior receptor binding capacity in in vitro assays.
What foods are highest in coumestrol?
Coumestrol is found in highest concentrations in sprouted legumes, particularly alfalfa sprouts (up to 4,700 µg per 100g dry weight), red clover sprouts, and soybean sprouts. Mature soybeans and split peas contain lower but meaningful amounts, while the coumestrol content of plants increases significantly during germination and sprouting due to stress-related isoflavonoid biosynthesis.
Can coumestrol help with menopause symptoms?
Coumestrol's high-affinity binding to ERβ—the predominant estrogen receptor in brain, bone, and cardiovascular tissue—provides a theoretical basis for alleviating vasomotor menopause symptoms such as hot flashes, but no dedicated human RCTs have confirmed this for isolated coumestrol. Evidence is largely extrapolated from broader phytoestrogen research and traditional use of coumestrol-rich plant preparations, so clinical recommendations cannot currently be made.
Is coumestrol safe for people with hormone-sensitive cancers?
Coumestrol is generally considered contraindicated for individuals with estrogen receptor-positive (ER+) breast, ovarian, or uterine cancers, as its near-estradiol binding affinity at ERα may stimulate tumor cell proliferation in vitro. Some research suggests ERβ-selective agonism could have anti-proliferative effects in certain cancer lines, but the dual ERα/ERβ activity of coumestrol makes its net effect in hormone-sensitive cancers unpredictable and potentially harmful without medical supervision.
Does coumestrol affect bone density?
Animal studies have shown that coumestrol can preserve bone mineral density in ovariectomized rodents by activating ERβ in osteoblasts, stimulating bone formation markers such as osteocalcin and alkaline phosphatase. However, these findings have not been replicated in human clinical trials using isolated coumestrol, and the effective doses used in rodent models do not have validated human equivalents, limiting direct application to bone health supplementation.
What is the difference between coumestrol and other phytoestrogens like genistein or daidzein?
Coumestrol is a coumestan-class phytoestrogen, structurally distinct from isoflavones like genistein and daidzein found in soy. While all three exhibit estrogenic activity through estrogen receptor binding, coumestrol demonstrates notably higher binding affinity to estrogen receptors (94–185% relative to estradiol) compared to most isoflavones. Coumestrol is less commonly studied than soy isoflavones but is found concentrated in legumes like alfalfa sprouts and clover.
Does coumestrol have any evidence for antioxidant benefits independent of its estrogenic effects?
Coumestrol possesses a chemical structure capable of free radical scavenging through its hydroxyl groups, suggesting antioxidant potential. However, most research on coumestrol focuses on its estrogenic receptor-binding activity rather than its standalone antioxidant properties in human studies. Any antioxidant benefits remain theoretically supported rather than clinically demonstrated in humans.
Does coumestrol interact with hormone replacement therapy (HRT) or hormonal contraceptives?
Coumestrol's competitive binding to estrogen receptors raises the theoretical possibility of interactions with HRT or contraceptives, though no clinical interaction studies have been conducted. Because coumestrol exerts estrogenic effects through the same receptor pathways as pharmaceutical hormones, concurrent use should be discussed with a healthcare provider. Anyone taking prescription hormone therapies should consult their physician before supplementing with coumestrol-containing products.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.